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Almost 20 years have passed since the recognition that thymus-derived lym- 
phocytes  belong  to  a  separate  differentiation  pathway  and  do  not  produce 
immunoglobulins (1, 2). However, the molecular structure of the antigen-specific 
receptor on T  cells remains an elusive goal necessary for understanding antigen- 
induced interactions among T  cells, B cells, and antigen-presenting ceils in the 
immune response. There is substantial evidence in support of similarity between 
immunoglobulin (Ig) idiotype (Id) and determinants expressed by antigen-specific 
T  cells. Anti-Id antibodies have been used to either stimulate or inhibit various 
T  cell functions (3-5),  and to demonstrate Ig-like Id determinants on antigen- 
specific T  cells (6-9) and the soluble factors they produce (10, 11). The definition 
of the T  cell receptor  is complicated by the existence of functionally distinct 
subsets of T  cells, each capable of expressing distinct antigen-specific molecules 
(12). A number of laboratories have established stable interleukin 2-dependent 
T  lymphocyte clones (13-15)  and T  cell hybrids derived from fusion between 
immune T  lymphocytes and cells of thymic lymphoma origin (11,  16-18). This 
approach should result in an increase in the yield of homogenous antigen-binding 
materials  produced  by  T  cells  and  thereby  facilitate  the  elucidation  of the 
molecular structure of the antigen-specific T  cell receptor. 
We  have  developed  two  mouse  monoclonal  anti-Id  antibodies  specific  for 
chicken antibodies to N-acetylglucosamine (NAGA) 1 and p-amino benzoic acid 
(PABA).  The anti-Id antibodies,  termed  CId-1  and  CId-2,  respectively,  were 
found  to  react  with  non-antigen-binding  Vn  determinants  (19).  The  CId-1 
antibody  reacted  by  indirect  immunofluorescence with  a  limited  number  of 
clones  of both  chicken  B  and  T  cells,  whereas  the  CId-2  antibody  reacted 
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exclusively with  Ig expressed by B  cells.  We have since  found that  the  CId-1 
antibody  recognizes a  conserved  determinant  expressed  by a  small  subset  of 
BALB/c  mouse  splenic  T  cells.  Encouraged  by  this  observation,  we  fused 
enriched CId-1 ÷ T  lymphocytes obtained from Streptococcus A-immune BALB/ 
c mice with the AKR BW 5147 cell line. Among the resulting 72 hybrids were 
two clones that reacted by indirect immunofluorescence with the CId-1  mono- 
clonal antibody. In this paper, we describe the generation of these T  cell hybrids 
and an initial characterization of their CId-1 determinants. 
Materials and  Methods 
Antisera.  The preparation and characterization of the monoclonal CId-1  and CId-2 
anti-Id antibodies (IgMx)  have been described (19).  The rat monoclonal antibodies to 
mouse Lyt-1 and Lyt-2, the mouse monoclonal antibodies to mouse I-A  d and I-A  k and 
monoclonal fluorescein isothiocyanate (FITC)-conjugated anti-Thy-l.2 antibodies were 
from Becton, Dickinson & Co., Sunnyvale, CA. The mouse anti-I-J  d and I-J  k alloantisera 
were gifts from Dr. Chella S. David, Mayo Clinic, Rochester, MN. The anti-H-2  d alloan- 
tiserum was a gift from Dr. Lori Flaherty, Albany, NY. Affinity-purified goat antibodies 
specific for mouse Ig isotypes were prepared as described (20). 
Immunization.  BALB/c mice (H-2  d) were immunized intraperitoneally three times at 
5-d intervals with 109 heat-killed Streptococcus group A strain J 17A4 (Strep A) organisms. 
Enrichment of Cld-1 ÷ Splenic T  Lymphocytes.  3 d after the last immunization, the mice 
were  killed  and  spleen  mononuclear cells were  isolated by centrifugation over Ficoll 
(Pharmacia  Fine  Chemicals,  Piscataway,  NY)-Hypaque  (Winthrop  Laboratories,  NY) 
gradients. To enrich for T  lymphocytes, the spleen cell suspension was panned twice on 
culture dishes (Costar, Data Packaging, Cambridge,  MA) precoated with  100 ~g/ml of 
affinity-purified goat anti-mouse Ig (21).  To enrich further for CId-1 ÷ T  lymphocytes, 
the nonadherent cells were treated with 200 ~g/ml of the CId-1 monoclonal antibody for 
30 min at 4°C, washed with phosphate-buffered saline (PBS) supplemented with 5% fetal 
calf serum (FCS),  and panned on dishes precoated with  100 ~g/ml of affinity-purified 
goat antibodies to mouse #  chains. After a  90-min incubation at 4°C, the dishes were 
washed five times with 5% FCS in PBS and 10 ml of complete RPMI 1640 medium (Gibco 
Laboratories, Grand Island,  NY) supplemented with  15%  FCS,  2  mM glutamine,  5  × 
10 -5 M 2-mercaptoethanol, 100 U/ml of penicillin, 100 #g/ml of streptomycin, and 0.25 
#g/ml of Fungizone (Gibco Laboratories, Grand Island, NY) were added to each plate. 
After a  1-h incubation at 37°C, the adherent cells were recovered with a sterile rubber 
policeman and washed before cell fusion. 
Cell Fusion and Cloning.  After enrichment for CId-1 ÷ cells, T cells were fused with the 
hypoxanthine guanosine phosphoribosyl transferase-resistant AKR (H-2  k) thymoma line 
BW 5147 and dispensed into 24-well culture dishes. Hybrid growth was detected 10-14 
d  after fusion. Screening for CId-1 ÷ T  cell hybrids was  performed using the indirect 
immunofluorescence assay described below. Hybrid cells were cloned by limiting dilution 
(22). 
Immunofluorescence  Screening for Cld-1 ÷ Hybrids.  The surface and cytoplasmic immuno- 
fluorescence techniques have been described (19). Capping of the CId-1 ÷ molecules was 
done by incubating CId-1  stained cells  at  37°C  for 20  min.  Cell  surface analysis  was 
performed by fluorescence microscopy and on a fluorescence-activated cell sorter (FACS 
IV; B-D FACS Systems, Becton, Dickinson & Co.) 
Lectin  Treatment ofCId-1 ÷ Hybrid Cells.  CId-IB hybrid cells at  106/mi were cultured 
overnight at 37°C in the presence of 10-20 #g/ml of concanavalin A (Con A), lentil lectin 
(LL), wheat germ agglutinin  (WGA) (Sigma Chemical Co.,  St.  Louis,  MO), pokeweed 
mitogen (PWM), and lipopolysaccharide (LPS), or with 2% phytohemagglutinin (PHA) 
(Gibco Laboratories). The surface distribution of the CId-1 determinant was then analyzed 
by immunofluorescence. 
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cells at 2 ×  106/ml were incubated with 0.5 ~g/ml of tunicamycin (Calbiochem-Behring 
Corp., LaJolla, CA) in complete RPMI 1640 overnight at :37 °C. For pronase and trypsin 
treatment, CId-IB cells were washed in Hanks' balanced salt solution (HBSS) at pH 7.9 
and cultured at 2 x  106/ml with 50-100 #g/ml of pronase (Caibiochem-Behring Corp.) 
or 25-50/~g/ml of trypsin (Gibco Laboratories)  in HBSS for 30 min at 37°C. The CId-1 
expression was then analyzed by the FACS IV. 
Results 
The  monoclonal  CId-1  Antibody  Cross-reacts with  BALB/c Splenic  T  Lymphocytes. 
BALB/c spleen cell suspensions were stained by indirect immunofluorescence 
with the CId-1  anti-Id antibody, followed by rhodamine isothiocyanate (RITC)- 
conjugated goat antibodies to mouse/~ chains, and counterstained with FITC- 
conjugated anti-Thy-l.2  or  rat  monoclonal  anti-Lyt-1  or  Lyt-2,  followed  by 
FITC-conjugated goat antibodies to rat IgG. Approximately 0.2%  of Thy-l.2  + 
BALB/c spleen  cells co-stained with  the monoclonal CId-1  antibody (Fig.  1). 
CId-1 + BALB/c spleen cells were equally distributed between the Lyt-1 + and 
the Lyt-2  + T  cell subsets. When the CId-1  antibody was replaced with a mono- 
clonal anti-chicken Ia antibody (23) as a  control IgM antibody in  the staining 
procedure, no doubly stained cells were found. 
Generation ofCId-1 + T Cell Hybrids.  BALB/c splenic T  cells, enriched for CId- 
1  + cells (see Materials and Methods), were fused with the AKR BW 5147  cell 
line and dispensed into  216  wells.  Among the resulting  72  wells with hybrid 
growth, two hybrids (CId-IA and CId-IB) reacted by indirect immunofluores- 
cence  with  the  monoclonal  CId-1  anti-Id  antibody  and  not  with  the  CId-2 
antibody.  None of the remaining 70  T  cell hybrids were reactive with either 
CId- 1 or CId-2. Essentially all CId- 1B hybrid cells stained with the CId- 1 antibody 
in a  ringlike pattern  of discrete mini-patches on the cell surface (Fig.  2).  The 
faint staining was confirmed by the FACS profiles of the CId-IA and CId-IB 
cells (Fig. 3). The fluorescence intensity exhibited by both the CId-IA and CId- 
1B  hybrids was  clearly above background,  but  "~ 10-20-fold  less  than  that  of 
BALB/c splenic B lymphocytes stained with goat anti-mouse #-chain antibodies 
(data not shown). The CId-1  surface staining of the CId-IB hybrids was com- 
pletely inhibited by preincubating the antibody with 20 ~g of affinity-purified 
chicken anti-NAGA but not with 80 ~g of anti-PABA antibodies. 
FIGURE  |.  CId-1  expression by Thy-1.2* BALB/c spleen cells in a  two-color immunofluo- 
rescence assay.  The cell indicated by arrow co-expressed the CId-1 and Thy-1.2 determinants: 
(A) phase contrast, (B) anti-Thy-1.2 staining, and (C) CId-1 staining. CHANH  AND  COOPER  455 
FIGURE 2.  CId-1 surface immunofluorescence staining of the CId-IB hybrid cells illustrating 
the circumferential patchy staining pattern. 
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FIGURE 3.  Fluorescence profiles  of(A) CId-lA and (B) CId-lB hybrid cells stained by indirect 
immunofluorescence  with CId-1 and CId-2 monoclonal  antibodies. 
To determine the intracellular distribution of CId-1 determinants, we exam- 
ined fixed CId-IA and CId-IB cells.  Diffuse patchy immunofluorescence with 
CId-1, but not with CId-2, antibody could be visualized in the cytoplasm of the 
CId-lA and B hybrid cells (Fig. 4). 
Cell Surface  Analysis  of CId-IA  and CId-IB Hybrids  and  the Parental AKR BW 
5147  Line.  The  cell  surface  phenotypes were  analyzed  with  a  fluorescence 
microscope and the FACS (Table I). Both CId-IA and CId-B hybrid cells lacked 
CId-2 and mouse Ig heavy- and light-chain determinants (Fig. 5). They stained 
with the anti-H-2  d ailoantiserum and with the monoclonal FITC-conjugated anti- 
Thy-l.2 antibody (Fig. 6A) and expressed the Lyt-1  antigen faintly (Fig. 6B) but 
lacked the Lyt-2 antigen. They expressed neither the parental I-A  d (BALB/c) 456  Vn  IDIOTOPE  ON  T  CELL  HYBRIDS 
FIGURE 4.  Cld-1  cytoplasmic immunofluorescence staining of the CId-IB hybrid cells: (A) 
phase contrast and (B) CId-1 cytoplasmic staining. A similar staining pattern was observed with 
the Cld-IA hybrid cells. 
(Fig. 6 C) nor the I-A  k (AKR) alleles but were positive for both the parental I-J  d 
and I-J  k alleles (Fig. 6D). The staining patterns of the CId-1B hybrids visualized 
by immunofluorescence with anti-Thy-l.2, anti-Lyt-1, anti-H-2  d, anti-I-J  d,  and 
anti-I-J  k antibodies were all distinct from that seen with the CId-1 antibody. 
The  CId-I  Determinant  Is  Distinct from  the  Thy-l.2,  Lyt-1,  H-2 d,  I-J  d,  and  I-J  k 
Molecules.  To determine whether the CId-1  determinant was physically associ- 
ated with Thy-l.2,  Lyt-1,  H-2 d,  I-J  d,  or I-J  k molecules on the cell membrane, 
CId-1B hybrid cells were incubated with the CId-1 antibody followed by RITC- CHANH  AND  COOPER  457 
TABLE  I 
hnmunofluorescence Analysis of Cell Surface Antigens on the CId-IA and Cld-IB Hybrids and the 
Parental BW 5147 Cell Line 
Antibody specificities 
CId-1  CId-2  Ig  ~ and ~  H-2  d  Thy-l.2  Lyt-1  Lyt-2  I-A  d  I-A  k  I-J  e  I-J  k 
BW5147  ...........  + 
Cld-IA  +  -  -  -  +  +  +  -  -  -  +  + 
CId-IB  +  -  -  -  +  +  +  -  -  -  +  + 
~Cld-2 
onti- mouse 
Fluorescence  Intensity  (too  scole) 
FIGURE  5.  CId-IB  hybrid  cells  lack  light chain determinants.  Fluorescence profiles of the 
CId-IB hybrid cells stained  with  CId-2 and affinity-purified  goat anti-mouse K- and  ~-chain 
antibodies.  [mmunofluorescence reactivity of the hybrid cells was also not seen with antibodies 
to mouse Ig,.,  7, ~, ¢, and a  determinants. 
A  JIl[f  CId'2  ti'Lyt  "1 
!I A  A: 
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FIGURE  6.  Fluorescence profiles of the Cld-1B hybrid cells stained with (A) anti-Thy-1.2, (B) 
d  d  anti-Lyt-1, (C) anti-I-A  , and (D) anti-I-J  and anti-I-J  k antibodies. 
conjugated goat antibodies  to mouse tz-chains under  capping conditions. The 
CId-IB cells were then stained either with CId-1  antibody followed by FITC- 
conjugated goat antibodies to mouse t~-chains to verify completeness of CId-1 
capping,  or  with  FITC-conjugated  anti-Thy-l.2  antibody.  After  the  CId-1 
marker was capped (Fig.  7), Thy-l.2  molecules were still distributed over the 
entire surface of the hybrid cells. Similarly, CId-1  antibody-induced capping of 
the CId-1  determinant did not result in co-capping of Lyt-1,  H-2 d, I-J  d, or I-J  k 458  VH  IDIOTOPE  ON  T  CELL  HYBRIDS 
FIGURE 7.  CId-I  antibody-induced capping of the Cld-1 determinant  does not result  in 
redistribution of the Thy-1.2 antigen:: (A) phase contrast, (B) CId-1 staining under capping 
conditions, and (C) anti-The,-1.2 staining after capping of the CId,1 marker. Similar results 
were obtained with the H-2  ~, Lyt-l, I-J  a, and I-J  k antigens. 
molecules. Reverse capping experiments were then performed with anti-I-J  a and 
-I-J  k alloantibodies.  Capping  of the  I-J  a  and  I-J  k  molecules  did  not  result  in 
redistribution of the CId-I  determinant 
Lectin-induced  Modulation  of the  CId-1  Determinant.  Since  most  cell  surface 
proteins are glycoproteins, we tested a panel of lectins for their ability to bind to 
and modulate the CId-1  determinant on the CId-IB hybrid cells. Incubation of 
CId-IB  hybrid  ceils  with  10-20  #g/ml  of Con  A  or  LL at  37°C  resulted  in 
capping of the CId-1  marker to one cellular pole (Fig. 8). Incubation of CId-IB 
hybrids with PHA, PWM,  LPS, or WGA had little or no apparent effect on the CHANH  AND  COOPER  459 
FIGURE 7C 
FIGURE 8.  Con A-induced capping  of the Cld-I  determinant:  (A) phase  contrast, and  (B) 
CId-1 staining after Con A treatment. 
surface distribution  of the CId-1  marker. Con  A- and LL-induced capping of 
CId-1 determinants did not result in co-capping of Thy-l.2, Lyt-1, H-2  d, I-J  d, or 
I-J  k molecules. These results suggest that the CId-1 marker is a glycoprotein and 
further support the idea that the CId-1  determinant is distinct from the Thy- 
1.2, Lyt-1, H-2  a, I-J  d, and I-J  k antigens. 
Effects of Tunicamycin,  Pronase,  and  Trypsin  on Expression of the CId-1  Determi- 
nant.  Incubation of the CId-IB hybrids with 0.5/~g/ml oftunicamycin resulted 
in a shift of fluorescence intensity to near background level (Fig. 9A). In contrast, 
immunofluorescence analysis of fixed cells revealed that the cytoplasmic expres- 
sion  of CId-1  determinants  was  not  reduced by  the  tunicamycin treatment. 
Incubation of CId-IB cells with 50-100  #g/ml of pronase or 25-50 #g/ml of 
trypsin also resulted in a shift of the fluorescence intensity of the treated cells to 460  Vn  IDIOTOPE  ON  T  CELL  HYBRIDS 
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FIGURE 9.  Fluorescence profiles of the Cld-I B hybrid cells before and after treatment with 
(A) tunicamycin, (B) pronase, and (C) trypsin. 
background level (Fig. 9,B and C). These results suggest that the CId-1  deter- 
minant is on a glycoprotein, and that glycosylation is required for normal surface 
expression of the molecule. 
Discussion 
The idiotope defined by the monoclonal CId-1  anti-Id antibody appeared to 
be a  non-binding-site-associated idiotope on the heavy chain of chicken anti- 
NAGA antibodies, which suggests a Vn Id (19). The CId-1  Id was found to be 
conserved in all outbred and inbred chickens tested, as evidenced by its expres- 
sion on "--20-25% of outbred and inbred chicken anti-NAGA antibodies and on 
1 and 0.4%  of chicken B and T  cells, respectively. Furthermore, the mono- 
clonal CId-1  anti-Id antibody was cross-reactive with 0.2%  of BALB/c mouse 
spleen cells that expressed the Thy-l.2 antigen. CId-1 ÷ BALB/c splenic T  cells 
were found by indirect immunofluorescence within both the Lyt-1 + and Lyt-2  ÷ 
T  cell subsets. The fact that CId-1 is a mouse IgM antibody precluded testing of 
its reactivity with mouse B cells by indirect immunofluorescence, but "-0.5% of 
human plasma cells expressed CId-1 ÷ molecules (unpublished observation). Idi- 
otypic cross-reactivity has been reported within inbred strains of mice (24,  25) 
and rabbits (26, 27), as well as between different strains of mice (28, 29). Idiotypic 
cross-reactivity has also been demonstrated between human and mouse, in the 
case  of phosphorylcholine-binding  myeloma proteins  (30)  and  antibodies  to 
acetylcholine receptor (31), and between goat and sheep antibodies to sickle cell 
hemoglobin (32). 
Based  on  the  observation  that  the  CId-1  antibody  reacted  with  a  limited 
number of BALB/c mouse T  cells, we fused enriched CId-1 ÷ BALB/c T  cells 
with the AKR BW 5147  line and generated two of 72 hybrids, termed CId-IA 
and CId-IB, that reacted with the monoclonal CId-1 anti-Id antibody. Both cell 
hybrids  lacked  mouse  Ig  determinants  and  detectable  Lyt-2  and  I-A  allelic 
determinants of both parental cells; each expressed the Thy-l.2, H-2  d, and I-J  d 
antigens of BALB/c origin, the I-J k antigen of AKR origin and the Lyt-1 antigen. 
These results suggest that both  CId-IA and CId-IB cells were T  cell hybrids 
resulting from fusion events between BALB/c and AKR cells. 
The relative immunofluorescence intensity of the CId-1  marker on CId-IA 
and CId-1B hybrids was "~ 10-20-fold less intense than that of BALB/c p-bearing 
splenic B lymphocytes stained with the same preparation of goat antibodies to CHANH  AND  COOPER  461 
mouse #-chains. Assuming that a mature B lymphocyte expresses ,~ 105 surface 
IgM molecules (33),  the CId-IA and CId-IB hybrids would appear to express 
"~5  ×  103  CId-1 + surface molecules per cell. This figure is consistent with the 
idea that the antigen-binding molecules on T cells may be 10-100-fold less dense 
than  that  expressed by B  cells,  and  with  the observation  that  T  cell hybrids 
synthesize extremely small  amounts of antigen-binding materials (34).  A  low 
density of antigen-binding molecules on the T  cell surface could also contribute 
to  the difficulty encountered in  demonstrating specific antigen binding by T 
cells. 
The  binding  of CId-1  antibody  to  the  CId-IB  hybrids  was  inhibited  by 
preincubating the antibody with affinity-purified chicken antibodies to NAGA, 
but not by antibodies to PABA. The lack of binding to the T  cell hybrids by the 
control CId-2 antibody and other mouse monoclonal antibodies of IgM isotype 
also strongly argues against the possibility of nonspecificity of the CId-1 binding 
to  the  CId-IB  hybrid  cells.  Moreover,  this  possibility  would  not  explain  the 
specific immunofluorescent staining of cytoplasmic constituents in the CId-IA 
and -1B hybrid cells after fixation. The latter observation may also be pertinent 
to future biosynthetic studies of the CId-1  molecule. 
The CId-1 surface marker could be easily capped by incubating CId-1B hybrid 
cells  with  the  CId-1  monoclonal  antibody  at  37°C.  CId-1  antibody-induced 
capping of the CId-1 determinant did not result in redistribution of other surface 
structures, including Thy-l.2, Lyt-1, H-2  a,  I-J  a,  and I-J  k.  Similarly, capping of 
the I-J  a and I-J  k determinants did not alter the global distribution of the CId-1 
determinant, which suggests that the CId-1  marker was not physically linked to 
these surface molecules. 
Con A, in subagglutinating concentrations, has recently been reported to block 
the function of cytotoxic T  cells, presumably by binding to surface structures 
essential for recognition or lysis of target cells (35). Incubation of CId-1 B hybrids 
with  Con  A  or  LL resulted  in  the capping of the CId-1  determinant to  one 
cellular pole, whereas incubation with PWM, PHA, LPS, or WGA did not alter 
surface distribution of the CId-1  determinant. The Con A-induced modulation 
of the CId-1 determinant did not result in a concomitant modulation of the Thy- 
1.2,  Lyt-1, H-2  a,  I-J  a, or I-J  k molecules, which further suggests that the CId-1 
determinant is a distinctive cell surface component. 
Treatment of CId-IB hybrids with tunicamycin, a compound that selectively 
prevents protein glycosylation (36),  dramatically reduced surface expression of 
CId-1 + molecules,  but  did  not  affect cytoplasmic expression  of the  antigen. 
Treatment of CId-1B hybrid cells with pronase or trypsin also resulted in a near- 
complete shift of fluorescence intensity of the CId-1  surface marker to back- 
ground level. Taken together, these results suggest that the CId-1 antigen is on 
a protein molecule that is glycosylated en route to the cell surface, where it can 
be modulated by Con A  or LL independently of the other surface structures 
recognized on the CId-1B hybrid cells. 
It  should  be  noted that  we have  no  evidence of antigen binding  or  other 
functional activity for the CId-1 + molecule on the T  cell hybrids CId-IA and 
CId-IB. However, the pool size of circulating CId-1 + T  cells in the chicken was 
selectively increased after injections of either the CId-1  antibody or Strep  A 462  VH  IDIOTOPE ON T  CELL HYBRIDS 
organisms bearing the NAGA antigen (19).  CId-1 + T  cells in mice represent a 
very  small  subpopulation  ("~0.2%)  of the  T  cell  pool.  Clonal  restriction  in 
expression of this Vn idiotope is further emphasized by its low incidence ('~3%) 
of expression by T  cell hybrids that were produced by fusion of T  cells, from an 
NAGA-immune donor,  preselected by adherence to  a  CId-1  antibody-coated 
plate. We conclude that these T cell hybrids, which express a surface glycoprotein 
recognized by the monoclonal CId-1 antibody with VH idiotope specificity, may 
provide a useful model system for identification and molecular characterization 
of the T  cell antigen receptor. 
Summary 
Two mouse monoclonai antibodies to chicken immunoglobulin Vmassociated 
idiotypes (Id),  CId-1  and CId-2,  were used as probes for Id determinants on 
mouse T  cells. CId-1, which recognized chicken antibodies to N-acetyl glucosa- 
mine (NAGA), and ~0.4% of chicken T  lymphocytes also reacted with '~0.2% 
of BALB/c splenic Thy-l.2  + cells. When enriched CId-1 ÷ splenic T  cells from 
NAGA-immune BALB/c mice were fused with the AKR thymoma BW  5147 
cell line, 2 of 72 resulting hybrids, termed CId-IA and CId-IB, were reactive by 
indirect immunofluorescence with the CId-1 antibody. CId-1 determinants were 
expressed both in the cytoplasm and on the cell surface. Immunofluorescence 
studies revealed that both CId-1 ÷ T  cell hybrids were phenotypically identical: 
CId-2-/Ig-/Lyt-l+2-/Thy-l.2+/H-2d+/I-Ad-/I-Ak-/I-Ja+/I-J k+.  Incubation  of 
CId-IB hybrid cells with concanavalin A  or lentil lectin resulted in capping of 
the CId-1 determinant, whereas incubation with pokeweed mitogen, lipopolysac- 
charide, phytohemagglutinin, and wheat germ agglutinin had no effect on the 
cell surface distribution of the CId-1  molecule. Trypsin or pronase treatment 
resulted in the loss of detectable CId-1  determinant on the cell surface. Treat- 
ment of CId-IB cells with tunicamycin also reduced the immunofluorescence 
intensity of the surface CId-1 determinant, but had no effect on its cytoplasmic 
expression. CId-1  antibody-induced capping of the CId-1  marker did not affect 
the surface distribution  of Lyt-1, Thy-l.2,  H-2  d,  I-J  d,  or  I-J k molecules. Con- 
versely, capping of I-J  d and I-J k determinants did not alter the surface distribution 
of CId-1. These results suggest that the CId-1  determinant is on a glycoprotein 
that is not physically linked to the Lyt-1, Thy-1.2, H-2  d, I-J  d, and I-J  k molecules. 
The clonai restriction of CId-1  expression by T  cells suggests that the CId-1 + 
molecule could be a T  cell antigen receptor. 
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